GoodRx Holdings (GDRX) Revenue (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Revenue data on file, last reported at $194.0 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 4.42% year-over-year to $194.0 million; the trailing twelve-month figure through Mar 2026 stood at $787.9 million (down 1.19% YoY), and the FY2025 full-year result was $796.9 million, up 0.57% from the prior year.
• Revenue was little changed at $194.0 million in Q1 2026, from $194.8 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $203.3 million in Q1 2022 to a low of $180.0 million in Q3 2023.
• A 5-year average of $194.1 million and a median of $195.3 million in 2024 frame the typical range for Revenue.
• Peak annual rise in Revenue reached 26.74% in 2022, while the deepest fall reached 13.67% in 2022.
• Tracing GDRX's Revenue over 5 years: stood at $184.1 million in 2022, then gained by 6.81% to $196.6 million in 2023, then rose by 0.99% to $198.6 million in 2024, then dropped by 1.91% to $194.8 million in 2025, then slipped by 0.4% to $194.0 million in 2026.
• Business Quant data shows GDRX's Revenue at $194.0 million in Q1 2026, $194.8 million in Q4 2025, and $196.0 million in Q3 2025.